Streetbeat News

Products Services

HII

Ingalls Shipbuilding has delivered the final Flight I San Antonio-class ship, Richard M. McCool Jr., to the U.S. Navy. This marks the 13th San Antonio-class ship delivered by Ingalls, concluding the Flight I transition and paving the way for the production of the LPD Flight II line.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 5:46 am

ARKB

BITO

HODL

Robert Kiyosaki, author of 'Rich Dad Poor Dad,' expressed his preference for direct ownership of assets over Bitcoin ETFs, despite his bullish outlook on Bitcoin. He emphasized his approach to financial independence and responsibility for his own investment decisions. Bitcoin ETFs like ProShares Bitcoin Strategy ETF (BITO), VanEck Bitcoin Trust (HODL), and ARK 21Shares Bitcoin ETF (ARKB) were mentioned as examples of the financial products Kiyosaki avoids.

Portfolio Pulse from Benzinga Neuro

April 12, 2024 | 5:15 am

AAPL

The increasing adoption of Apple Inc.'s Macs in corporate environments has attracted sophisticated hackers, including North Korea's Lazarus Group, targeting the platform's security vulnerabilities. The Transparency, Consent, and Control (TCC) framework of macOS, crucial for user privacy and app permissions, is being exploited for unauthorized access. Despite Apple's security updates, vulnerabilities like the Finder's default Full Disk Access pose significant risks. Companies are urged to adopt protective measures against these threats.

Portfolio Pulse from Ananya Gairola

April 12, 2024 | 4:28 am

AAPL

NVDA

Jim Cramer, a CNBC financial commentator, has voiced his support for Federal Reserve Chair Jerome Powell, NVIDIA's CEO Jensen Huang, and Apple's CEO Tim Cook, against Wall Street's skepticism. Cramer praised Powell's leadership, defended NVIDIA against concerns of competition in graphics chips, and dismissed the notion that Apple is in a no-growth phase, citing plans to revamp its Mac line with AI chips. He encouraged Wall Street to trust in their ability to deliver positive results, highlighting his successful track record with these figures.

Portfolio Pulse from Benzinga Neuro

April 12, 2024 | 3:08 am

AAPL

AMZN

NKLA

RIVN

TSLA

On Thursday, major U.S. stock market indexes closed higher, with notable movements in shares of Apple, Rivian, Amazon, Nikola, and Tesla. Apple's stock rose by 4.33% amid news of a Mac line overhaul and the development of the M4 processor. Rivian's shares fell to a new all-time low, dropping by 6.82% due to concerns about the company's future. Amazon's stock reached a new all-time high, increasing by 1.67%, as CEO Andy Jassy emphasized the company's focus on artificial intelligence. Nikola's shares plummeted by 26.73% following a Peer Perform rating from Wolfe Research, citing infrastructure and cost challenges. Tesla's stock increased by 1.65%, showing signs of recovery amidst market turbulence.

Portfolio Pulse from Benzinga Neuro

April 12, 2024 | 2:04 am

COIN

HOOD

MSFT

PLTR

TSLA

Ark Invest, led by Cathie Wood, announced an investment in OpenAI through the Ark Venture Fund. This investment gives exposure to various companies including private entities like SpaceX and public companies such as Microsoft, which has invested $13 billion in OpenAI. The Ark Venture Fund, with $53.7 million in assets, has seen a 34.7% increase in the net asset value of shares over the past year. Top public holdings include Coinbase, Robinhood, Palantir, and Tesla.

Portfolio Pulse from Chris Katje

April 11, 2024 | 10:22 pm

MSTR

Peter Schiff predicts a significant crash for Bitcoin, attributing it to speculative ETF buyers selling off, leading to a lack of liquidity. He also foresees a potential bankruptcy for MicroStrategy (NASDAQ:MSTR) due to its heavy investment in Bitcoin. Schiff criticizes the blockchain and Bitcoin as a 'Digital Ponzi' scheme and questions MicroStrategy's financial strategies. Despite Bitcoin's recent losses, analysts predict its holdings will increase significantly by 2025.

Portfolio Pulse from Khyathi Dalal

April 11, 2024 | 9:53 pm

BIO

OCX

Oncocyte has entered into a partnership agreement with Bio-Rad Laboratories for the global launch of a transplant assay, expected in Q2 2024. The deal includes a co-marketing arrangement in the US and Germany, with Oncocyte as the commercial lead. Bio-Rad will have exclusive global distribution and commercial rights outside these countries and an option for IVD commercial rights upon FDA clearance. Bio-Rad also plans to make an equity investment in Oncocyte as part of the agreement.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 9:32 pm

UTI

Universal Technical Institute has partnered with iRacing to enhance NASCAR Mechanic Technician Training. The collaboration allows students to use iRacing's virtual racing experiences alongside a 15-week hands-on training program focused on engines, fabrication, and chassis applications.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 9:24 pm

KYTX

Kyverna Therapeutics announced its attendance at the 2024 AAN Annual Meeting, where it will present data on KYV-101, a treatment for patients with neurological autoimmune diseases.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 9:16 pm